Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 18

1.

Insights into the poor prognosis of allopurinol-induced severe cutaneous adverse reactions: the impact of renal insufficiency, high plasma levels of oxypurinol and granulysin.

Chung WH, Chang WC, Stocker SL, Juo CG, Graham GG, Lee MH, Williams KM, Tian YC, Juan KC, Jan Wu YJ, Yang CH, Chang CJ, Lin YJ, Day RO, Hung SI.

Ann Rheum Dis. 2014 Aug 12. pii: annrheumdis-2014-205577. doi: 10.1136/annrheumdis-2014-205577. [Epub ahead of print]

PMID:
25115449
[PubMed - as supplied by publisher]
2.

Reduced renal clearance of cefotaxime in asians with a low-frequency polymorphism of OAT3 (SLC22A8).

Yee SW, Nguyen AN, Brown C, Savic RM, Zhang Y, Castro RA, Cropp CD, Choi JH, Singh D, Tahara H, Stocker SL, Huang Y, Brett CM, Giacomini KM.

J Pharm Sci. 2013 Sep;102(9):3451-7. doi: 10.1002/jps.23581. Epub 2013 May 6.

PMID:
23649425
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Understanding the dose-response relationship of allopurinol: predicting the optimal dosage.

Graham GG, Kannangara DR, Stocker SL, Portek I, Pile KD, Indraratna PL, Datta I, Williams KM, Day RO.

Br J Clin Pharmacol. 2013 Dec;76(6):932-8. doi: 10.1111/bcp.12126.

PMID:
23590252
[PubMed - indexed for MEDLINE]
4.

HLA-B*5801 should be used to screen for risk of Stevens-Johnson syndrome in family members of Han Chinese patients commencing allopurinol therapy.

Lee MH, Stocker SL, Williams KM, Day RO.

J Rheumatol. 2013 Jan;40(1):96-7. doi: 10.3899/jrheum.120803. No abstract available.

PMID:
23280169
[PubMed - indexed for MEDLINE]
5.

Gene expression profiling of transporters in the solute carrier and ATP-binding cassette superfamilies in human eye substructures.

Dahlin A, Geier E, Stocker SL, Cropp CD, Grigorenko E, Bloomer M, Siegenthaler J, Xu L, Basile AS, Tang-Liu DD, Giacomini KM.

Mol Pharm. 2013 Feb 4;10(2):650-63. doi: 10.1021/mp300429e. Epub 2013 Jan 24.

PMID:
23268600
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

The effect of novel promoter variants in MATE1 and MATE2 on the pharmacokinetics and pharmacodynamics of metformin.

Stocker SL, Morrissey KM, Yee SW, Castro RA, Xu L, Dahlin A, Ramirez AH, Roden DM, Wilke RA, McCarty CA, Davis RL, Brett CM, Giacomini KM.

Clin Pharmacol Ther. 2013 Feb;93(2):186-94. doi: 10.1038/clpt.2012.210. Epub 2012 Oct 17.

PMID:
23267855
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Renal transporters in drug development.

Morrissey KM, Stocker SL, Wittwer MB, Xu L, Giacomini KM.

Annu Rev Pharmacol Toxicol. 2013;53:503-29. doi: 10.1146/annurev-pharmtox-011112-140317. Epub 2012 Nov 8. Review.

PMID:
23140242
[PubMed - indexed for MEDLINE]
8.

Fractional clearance of urate: validation of measurement in spot-urine samples in healthy subjects and gouty patients.

Kannangara DR, Ramasamy SN, Indraratna PL, Stocker SL, Graham GG, Jones G, Portek I, Williams KM, Day RO.

Arthritis Res Ther. 2012 Aug 17;14(4):R189. doi: 10.1186/ar4020.

PMID:
22901830
[PubMed - in process]
Free PMC Article
9.

The pharmacokinetics of oxypurinol in people with gout.

Stocker SL, McLachlan AJ, Savic RM, Kirkpatrick CM, Graham GG, Williams KM, Day RO.

Br J Clin Pharmacol. 2012 Sep;74(3):477-89. doi: 10.1111/j.1365-2125.2012.04207.x.

PMID:
22300439
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Initiating allopurinol therapy: do we need to know the patient's human leucocyte antigen status?

Lee MH, Stocker SL, Anderson J, Phillips EJ, Nolan D, Williams KM, Graham GG, Sullivan JR, Day RO.

Intern Med J. 2012 Apr;42(4):411-6. doi: 10.1111/j.1445-5994.2011.02567.x.

PMID:
21790926
[PubMed - indexed for MEDLINE]
11.

Pharmacokinetic and pharmacodynamic interaction between allopurinol and probenecid in patients with gout.

Stocker SL, Graham GG, McLachlan AJ, Williams KM, Day RO.

J Rheumatol. 2011 May;38(5):904-10. doi: 10.3899/jrheum.101160. Epub 2011 Feb 1.

PMID:
21285173
[PubMed - indexed for MEDLINE]
12.

Lack of effect of hydrochlorothiazide and low-dose aspirin on the renal clearance of urate and oxypurinol after a single dose of allopurinol in normal volunteers.

Ng DY, Stocker SL, Graham GG, Williams KM, Day RO.

Eur J Clin Pharmacol. 2011 Jul;67(7):709-13. doi: 10.1007/s00228-010-0963-6. Epub 2010 Dec 23.

PMID:
21181139
[PubMed - indexed for MEDLINE]
13.

A proposal for identifying the low renal uric acid clearance phenotype.

Indraratna PL, Stocker SL, Williams KM, Graham GG, Jones G, Day RO.

Arthritis Res Ther. 2010;12(6):149. doi: 10.1186/ar3191. Epub 2010 Dec 16.

PMID:
21162713
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Measurement of urinary oxypurinol by high performance liquid chromatography-tandem mass spectrometry.

Stocker SL, Franklin ME, Anderson JM, Pillans PI, Williams KM, McLachlan AJ, Day RO, Taylor PJ.

J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Sep 1;878(25):2363-8. doi: 10.1016/j.jchromb.2010.07.017. Epub 2010 Jul 29.

PMID:
20702150
[PubMed - indexed for MEDLINE]
15.

Optimizing therapy with allopurinol: factors limiting hypouricemic efficacy.

Chung Y, Stocker SL, Graham GG, Day RO.

Am J Med Sci. 2008 Mar;335(3):219-26. doi: 10.1097/MAJ.0b013e31815acb10. Review.

PMID:
18344696
[PubMed - indexed for MEDLINE]
16.

Pharmacokinetic and pharmacodynamic interaction between allopurinol and probenecid in healthy subjects.

Stocker SL, Williams KM, McLachlan AJ, Graham GG, Day RO.

Clin Pharmacokinet. 2008;47(2):111-8.

PMID:
18193917
[PubMed - indexed for MEDLINE]
17.

Clinical pharmacokinetics and pharmacodynamics of allopurinol and oxypurinol.

Day RO, Graham GG, Hicks M, McLachlan AJ, Stocker SL, Williams KM.

Clin Pharmacokinet. 2007;46(8):623-44. Review.

PMID:
17655371
[PubMed - indexed for MEDLINE]
18.

When debiasing backfires: accessible content and accessibility experiences in debiasing hindsight.

Sanna LJ, Schwarz N, Stocker SL.

J Exp Psychol Learn Mem Cogn. 2002 May;28(3):497-502.

PMID:
12018501
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk